BSE filing, NSE: KANSAINER. Summary written from the filing by ALFA Finder's alert engine.
Kansai Nerolac Paints Ltd: key numbers
- Share price
- ₹180.74
- Market cap
- ₹14,620 Cr
- Revenue (annual)
- ₹8,052 Cr
- Net profit (annual)
- ₹589.5 Cr
- P/E (TTM)
- 24.4×Sector 42.1×
- Promoter holding
- 74.95%-0.01% QoQ
- FII holding
- 3.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kansai Nerolac Paints Ltd
All →Kansai Nerolac Paints Acquisition
Kansai Nerolac Paints announced the NCLT sanctioned the Scheme of Amalgamation of Nerofix Private Limited with the company. The merger aims for operational synergy and scale.
Kansai Nerolac Paints Board Meeting Date
Kansai Nerolac Paints will hold a board meeting on November 4, 2026, to consider its quarterly and half-yearly unaudited financial results. Trading window closure is announced.
Kansai Nerolac Paints Employee Stock Options
Kansai Nerolac Paints Limited has allotted 75,801 equity shares following the exercise of Restricted Stock Units. The allotment was made under the company's RSU Plan 2022.
Kansai Nerolac Paints Legal & Regulatory
Kansai Nerolac Paints received a GST order from the Joint Commissioner of State Tax, reducing the penalty amount to Rs. 1.46 Crore.
- Value
- ₹1.46 Cr
Kansai Nerolac Paints Investor Presentation: Key Takeaways
KNPL reported Q1 FY27 standalone net revenue growth of 10.2% and PBDIT growth of 7.7%, focusing on premiumization in decorative and industrial segments.
Kansai Nerolac Paints Investor Presentation: Key Takeaways
Kansai Nerolac reports Q1 FY27 results, focusing on 'Paint+' product strategy, network expansion, and technology leadership in industrial coatings.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date